The use of negative pressure in the treatment of secondary arm lymphoedema and fibrosis in post-breast cancer patients
Not yet recruiting
- Conditions
- lymphoedematissue fibrosisbreast cancer
- Registration Number
- ACTRN12617001574336
- Lead Sponsor
- eil Piller
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- Female
- Target Recruitment
- 12
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie negative pressure therapy for lymphatic fibrosis in breast cancer survivors?
How does negative pressure therapy compare to manual lymph drainage for post-breast cancer lymphoedema management?
Which biomarkers correlate with treatment response to negative pressure in secondary lymphoedema patients?
What adverse events are associated with negative pressure devices for lymphatic tissue remodeling?
Are there combination therapies with negative pressure to enhance fibrosis resolution in breast cancer-related lymphoedema?